Literature DB >> 17891582

Preparation of budesonide-poly (ethylene oxide) solid dispersions using supercritical fluid technology.

Hui Liu1, Li-Li Zhou, Lan-Lan Wei, Shu-Fang Nie, Xing-Gang Yang, Ren Tang, Wei-San Pan.   

Abstract

The purpose of this study was to investigate the possibility of preparing solid dispersions of the poorly soluble budesonide by supercritical fluid (SCF) technique, using poly (ethylene oxide) (PEO) as a hydrophilic carrier. The budesonide-PEO solid dispersions were prepared, using supercritical carbon dioxide (SC CO(2)) as the processing medium, and characterized by scanning electron microscopy (SEM), powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), solubility test and dissolution test in order to understand the influence of the SCF process on the physical status of the drug. The endothermic peak of budesonide in the SCF-treated mixtures was significantly reduced, indicating that budesonide was in amorphous form inside the carrier system. This was further confirmed by SEM and PXRD studies. The enhanced dissolution rates of budesonide were observed from SCF-treated budesonide-PEO mixtures. The amorphous characteristic of the budesonide, the better mixing of drug and PEO powders in the presence of SC CO(2), together with the improved wettability of the drug in PEO, produced a remarkable enhancement of the in vitro drug dissolution rate. Thus, budesonide-PEO solid dispersions with enhanced dissolution rate can be prepared using organic solvent-free SCF process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17891582     DOI: 10.1080/03639040601134181

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  3 in total

1.  Development of self-microemulsifying drug delivery system and solid-self-microemulsifying drug delivery system of telmisartan.

Authors:  Parul Jaiswal; Geeta Aggarwal; Sasidharan Leelakumari Harikumar; Kashmir Singh
Journal:  Int J Pharm Investig       Date:  2014-10

2.  A Repurposed Drug for Brain Cancer: Enhanced Atovaquone Amorphous Solid Dispersion by Combining a Spontaneously Emulsifying Component with a Polymer Carrier.

Authors:  Hiroyuki Takabe; Zachary N Warnken; Yajie Zhang; Daniel A Davis; Hugh D C Smyth; John G Kuhn; Steve Weitman; Robert O Williams Iii
Journal:  Pharmaceutics       Date:  2018-05-19       Impact factor: 6.321

3.  Solubility Enhancement of Ibuprofen by Adsorption onto Spherical Porous Calcium Silicate.

Authors:  Yayoi Kawano; Shiyang Chen; Takehisa Hanawa
Journal:  Pharmaceutics       Date:  2021-05-21       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.